Discovery of a Bromodomain and Extraterminal Inhibitor with a Low Predicted Human Dose through Synergistic Use of Encoded Library Technology and Fragment Screening
Year: 2020
Type: article
Source: Journal of Medicinal Chemistry
Authors: Christopher R. Wellaway, Dominique Amans, Paul Bamborough, Heather Barnett, Rino A. Bit, Jack A. Brown, Neil R. Carlson, Chun-wa Chung, Anthony W. J. Cooper, Peter D. Craggs, Robert P. Davis, Tony W. Dean, John P. Evans, Laurie Gordon, Isobel L. Harada, David J. Hirst, Philip G. Humphreys, Katherine L. Jones, Antonia J. Lewis, Matthew J. Lindon, Dave Lugo, Mahnoor Mahmood, Scott McCleary, Patricia Medeiros, Darren J. Mitchell, Michael O’Sullivan, Armelle Le Gall, Vipulkumar K. Patel, Chris Patten, Darren L. Poole, Rishi R. Shah, Jane E. Smith, Kayleigh A. J. Stafford, Pamela J. Thomas, Mythily Vimal, Ian D. Wall, Robert J. Watson, Natalie Wellaway, Gang Yao, Rab K. Prinjha
Institution: GlaxoSmithKline (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3000211595
